Dec 28, 2019

Henry Schein Q4 2019 Earnings Report

Reported record Q4 2019 financial results from continuing operations.

Key Takeaways

Henry Schein reported a 7.9% increase in net sales from continuing operations, reaching $2.7 billion. GAAP diluted EPS was $2.25, up 192.2% year-over-year, while non-GAAP diluted EPS was $0.97, a 9.0% increase. The company affirms its 2020 non-GAAP diluted EPS guidance of $3.65 to $3.75.

GAAP diluted EPS from continuing operations increased by 192.2% year-over-year to $2.25, driven by a net gain on the sale of equity investments.

Non-GAAP diluted EPS from continuing operations grew by 9.0% year-over-year to $0.97.

Net sales from continuing operations rose by 7.9% to $2.7 billion, with 8.9% growth in local currencies.

The company repurchased approximately 2.9 million shares of its common stock during the fourth quarter for $200 million.

Total Revenue
$2.67B
Previous year: $3.38B
-20.9%
EPS
$0.97
Previous year: $1.12
-13.4%
Gross Profit
$811M
Previous year: $910M
-10.9%
Cash and Equivalents
$106M
Previous year: $80.2M
+32.3%
Total Assets
$7.15B
Previous year: $8.5B
-15.9%

Henry Schein

Henry Schein

Henry Schein Revenue by Segment

Henry Schein Revenue by Geographic Location

Forward Guidance

Henry Schein affirmed 2020 non-GAAP diluted EPS guidance of $3.65 to $3.75, reflecting growth of 4% to 7% compared with 2019.

Positive Outlook

  • 2020 non-GAAP diluted EPS from continuing operations attributable to Henry Schein, Inc. is expected to be $3.65 to $3.75.
  • Guidance assumes no significant supply chain disruption related to the Novel Coronavirus Disease 2019 (COVID-19) for certain infection control products.
  • Guidance is for current continuing operations as well as completed or previously announced acquisitions.
  • Guidance does not include the impact of potential future acquisitions, if any, and restructuring expenses.
  • Guidance assumes foreign exchange rates that are generally consistent with current levels, and that end markets remain stable and are consistent with current market conditions.

Challenges Ahead

  • Company is not providing 2020 GAAP diluted EPS guidance.
  • Unable to provide an accurate estimate of expenses related to a planned restructuring.
  • Restructuring is intended to mitigate stranded costs associated with the spin-off of its Animal Health business.
  • Restructuring is intended to drive operating efficiencies.
  • Inability to provide these reconciliations is due to the uncertainty and inherent difficulty of predicting the occurrence, the financial impact, and the periods in which the non-GAAP adjustments may be recognized.

Revenue & Expenses

Visualization of income flow from segment revenue to net income